Latest filing published 06 Jun 2025 for NeuroPace Inc, €16k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Rebecca Kuhn (finance chief) discloses dealings in NeuroPace Inc to SEC (Form 4). We count 40 filings; the first trade dates from 4 June 2021 and the latest from 3 June 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 6 June 2025, the filings show a share grant worth €16k in NeuroPace Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations